banner ad
banner ad

Aesthetic Medicine / MediSpa News

Allergan thrives with Botox but is unloading Lap-Band

March 7, 2013 |

Drug maker Allergan posted record sales in 2012, with wrinkle remover Botox its top seller, but plans to sell its Lap-Band unit amid falling sales and patient deaths. This is the company that makes Botox. The wrinkle-erasing drug is Allergan’s top-selling product with sales expected to reach $2 billion in 2013. But there’s more to […]

Read More

US study: Botox reduces symptoms of depression

March 6, 2013 |

A recent study in the US has found that using Botox to combat frown lines reduced the symptoms of severe depression in more than a quarter of patients. The decade long research into the benefits of Botox for the severely depressed found that injecting Botox into your furrows or ‘grief muscles’ can actually make you […]

Read More

Stem Cells Printer: What the New Innovation Means for Aesthetic Medicine

March 5, 2013 |

On February 5, 2013 Scientific American has published a report that the University of Edinburgh has successfully finished a study which led to the production of a live embryonic stem cells-discharging printer. The breakthrough printer releases uniformly-sized cell droplets such that the living cells could be used to mutate into a number of cell types. […]

Read More

EU Rejects Obesity Drug Qsiva for the Second Time

February 26, 2013 |

The European Medicines Agency (EMA) has again refused to grant approval for the new obesity treatment phentermine/extended-release (ER) topiramate (Qsiva, Vivus) in the European Union. The EMA’s Committee for Medicinal Products for Human Use (CHMP) first rejected the product in October but was asked  by the company to reexamine the decision. Defending its second rebuttal, the CHMP said it “has   […]

Read More

Minimally-Invasive, Facial Rejuvenation Procedures Fuel 5% Growth

February 20, 2013 |

As economic indicators such as auto, retail, and home sales saw gains in 2012 – so too did plastic surgery. According to statistics released today by the American Society of Plastic Surgeons (ASPS), 14.6 million cosmetic plastic surgery procedures, including both minimally-invasive and surgical, were performed in the United States in 2012, up 5 percent […]

Read More

Dr. Oz changes his mind about the HCG diet

February 11, 2013 |

Dieters say the weight loss achieved from the use of HCG compares to lap band or gastic bypass —  without the surgery. HCG — which stands for “human chorionic gonadotropin” — is the hormone produced during pregnancy to keep the baby healthy. Advocates say HCG can also trick the body into burning fat. Many reputable […]

Read More

HCG Diet for Weight Loss Debated on The Dr. Oz Show

February 7, 2013 |

HCG (human chorionic gonadotropin) is a hormone made by the placenta in women during pregnancy that helps support the normal growth and development of a fetus. Since the 1950s, however, HCG has been promoted for weight loss through a low calorie HCG diet that the FDA warns is dangerous. Last year on the Dr. Oz […]

Read More

Botox stomach injections won’t help you lose weight: Study

January 30, 2013 |

Not just for wrinkles anymore, Botox is being tested to treat a myriad of ailments, from migraines to foot pain. But the facial freezer won’t help you shed kilos, as researchers say that while Botox injected into the stomach may help slow the movement of food in the stomach, it won’t keep you from eating […]

Read More

Hyaluronidase: fix dermal filler mistakes

January 24, 2013 |

Non-animal, stabilized hyaluronic acid (NASHA) gels have become a very popular dermal filler material. In the past, if an error was made in filler quantity or placement, the solution was to wait for the material to reabsorb over several months. Hyaluronidase is an enzyme that catalyzes the breakdown of hyaluronic acid in the body, thereby […]

Read More

Xeomin cleared to re-enter U.S. market

January 18, 2013 |

Having reached the end of a 10-month injunction barring it from selling its botulinum toxin product in the U.S., Merz is once again launching Xeomin for the treatment of glabellar lines. Xeomin (incobotulinumtoxinA) was shelved in the U.S. in March 2012 after a federal court concluded Merz stole trade secrets such as customer lists and […]

Read More

banner ad
banner ad